UNIT 5.5 Production of Polyclonal Antisera

  1. Helen M. Cooper1,
  2. Yvonne Paterson2

Published Online: 1 JUL 2009

DOI: 10.1002/0471142301.ns0505s48

Current Protocols in Neuroscience

Current Protocols in Neuroscience

How to Cite

Cooper, H. M. and Paterson, Y. 2009. Production of Polyclonal Antisera. Current Protocols in Neuroscience. 48:5.5:5.5.1–5.5.10.

Author Information

  1. 1

    Queensland Brain Institute and University of Queensland, Brisbane, Australia

  2. 2

    University of Pennsylvania, Philadelphia, Pennsylvania

Publication History

  1. Published Online: 1 JUL 2009
  2. Published Print: JUL 2009


Much of modern biology and biochemistry relies on the availability of highly specific antibodies for use in such ubiquitous techniques as immunohistochemistry, ELISAs, immunoprecipitation, and immunoblotting. Thus, the generation of large quantities of specific antibodies directed against proteins or peptides of interest is essential to the success of both basic and applied research programs. In addition, with the advent of antibody-based proteomic strategies for profiling protein expression and post-translational modification, a requirement for timely production of specific antibodies has been exemplified. Polyclonal antibodies derived from animals immunized with purified proteins or peptides are particularly valuable for use in the laboratory. This unit provides protocols for the production of polyclonal antisera specific for protein antigens using rabbits, rats, mice, and hamsters.Curr. Protoc. Neurosci. 48:5.5.1-5.5.10. © 2009 by John Wiley & Sons, Inc.


  • polyclonal antiserum;
  • adjuvant;
  • antigen;
  • immunization